KarmaCare Dx At A Glance

KarmaCare Dx is KPC Biotech’s molecular diagnostic laboratory business unit.  We help healthcare professionals to quickly diagnose and treat their patients with precision and confidence.  Offering a full menu of Infectious Disease testing services, we support providers with rapid detection and identification of viral, bacterial, and fungal pathogens with detailed reports.  Our syndromic panels include identifications of antimicrobial resistance genes and valuable recommendations of antibiotic treatment for improved patient outcome.

We serve out customers from KPC Biotech Molecular Laboratory, a CLIA Accredited (CLIA ID# 05D2227042) and CDPH Certified (ID# CDF-90004447) laboratory in Southern California, and through our value-added CLIA and CAP-Certified network of laboratory partners nationwide.

Advantages of PCR-based Testing with KarmaCare Dx

Advantages of PCR-based Testing with KarmaCareDx

About KPC Biotech

KPC Biotech is a U.S.-based company delivering projects of purpose that improve health, life, and longevity through science. We provide innovative medical diagnostic solutions that help accelerate treatment, prevent dispersion, and minimize costs.

From our research laboratories to the front lines where we continuously support hospitals and physicians nationwide, our success is attributed through our ability to customize our services to meet the individual needs of our customers, partners, and sponsors. We are committed to delivering the best possible solutions for those we serve. Our team consists of a stellar group of highly seasoned scientists and physicians with vast experience in clinical diagnostics, and business professionals that are passionate about making a difference, to support our products and high-value service offerings.

We believe in collaboration and leverage our expertise with a wide network of specialized scientific and clinical resources, including our group companies in the healthcare sectors:

  • KPC Health – An integrated healthcare delivery systems consisting of:
    • 17 Acute Care Hospitals
    • Over 1,200 Inpatient beds collectively
    • 1,700 + Active physicians, and
    • Nearly 5,000 Hospital personnel
  • Sub-acute Hospitals
  • Skilled Nursing Facilities
  • Independent Physicians Associations (IPAs)
  • Medical Groups
  • Health Management Organizations (HMO’s)
  • Urgent Care Facilities, and
  • various fully integrated multi-specialty medical facilities throughout the United States

About KPC Biotech

KPC Biotech is a U.S.-based company delivering projects of purpose that improve health, life, and longevity through science. We provide innovative medical diagnostic solutions that help accelerate treatment, prevent dispersion, and minimize costs.

From our research laboratories to the front lines where we continuously support hospitals and physicians nationwide, our success is attributed through our ability to customize our services to meet the individual needs of our customers, partners, and sponsors. We are committed to delivering the best possible solutions for those we serve. Our team consists of a stellar group of highly seasoned scientists and physicians with vast experience in clinical diagnostics, and business professionals that are passionate about making a difference, to support our products and high-value service offerings.

We believe in collaboration and leverage our expertise with a wide network of specialized scientific and clinical resources, including our group companies in the healthcare sectors:

  • KPC Health – An integrated healthcare delivery systems consisting of:
    • 17 Acute Care Hospitals
    • Over 1,200 Inpatient beds collectively
    • 1,700 + Active physicians, and
    • Nearly 5,000 Hospital personnel
  • Sub-acute Hospitals
  • Skilled Nursing Facilities
  • Independent Physicians Associations (IPAs)
  • Medical Groups
  • Health Management Organizations (HMO’s)
  • Urgent Care Facilities, and
  • various fully integrated multi-specialty medical facilities throughout the United States

Our service offerings consist of Clinical and Analytical Validation of Laboratory Developed Tests (LDTs), Invitro Diagnostics (IVDs), Point-Of-Care (POCs) and Over-The-Counter (OTCs) Tests, Molecular Diagnostic Laboratory Services, and Commercialization and Distribution. We support our customers, partners, and sponsors through our three fully integrated business segments:

Integrated Business Units

KarmaCare DxTM is KPC Biotech’s molecular diagnostic laboratory business unit. We help healthcare professionals to quickly diagnose and treat their patients with precision and confidence. Offering a full menu of Infectious Disease testing services, we support providers with rapid detection and identification of viral, bacterial, and fungal pathogens with detailed reports. Our syndromic panels include identifications of antimicrobial resistance genes and valuable recommendations of antibiotic treatment for improved patients’ outcomes.

KarmaCare InnovationTM is a service provider and a development partner to biotechnology and pharmaceutical companies in the global medical diagnostic market. We offer gold standard methodologies for clinical and analytical validation of Laboratory Developed Tests (LDTs), Invitro Diagnostics (IVDs), Point-Of-Care (POCs), and Over-The-Counter (OTCs) Tests with custom services and quality at scale. We contribute to cost-effective healthcare that works worldwide; providing our clients and partners with end products that make state-of-the-art medical diagnostics possible.

KarmaCare DirectTM supplies high-quality diagnostic tests for diagnosis of infectious diseases and health & wellness products to physicians, medical and healthcare organizations, laboratories, health insurance companies, direct to consumers, and commercial and government entities. Our products include KarmaCare and Karmaceutical brands as well as carefully selected and validated partner products.

Integrated Business Units

KarmaCare DxTM is KPC Biotech’s molecular diagnostic laboratory business unit. We help healthcare professionals to quickly diagnose and treat their patients with precision and confidence. Offering a full menu of Infectious Disease testing services, we support providers with rapid detection and identification of viral, bacterial, and fungal pathogens with detailed reports. Our syndromic panels include identifications of antimicrobial resistance genes and valuable recommendations of antibiotic treatment for improved patients’ outcomes.

KarmaCare InnovationTM is a service provider and a development partner to biotechnology and pharmaceutical companies in the global medical diagnostic market. We offer gold standard methodologies for clinical and analytical validation of Laboratory Developed Tests (LDTs), Invitro Diagnostics (IVDs), Point-Of-Care (POCs), and Over-The-Counter (OTCs) Tests with custom services and quality at scale. We contribute to cost-effective healthcare that works worldwide; providing our clients and partners with end products that make state-of-the-art medical diagnostics possible.

KarmaCare DirectTM supplies high-quality diagnostic tests for diagnosis of infectious diseases and health & wellness products to physicians, medical and healthcare organizations, laboratories, health insurance companies, direct to consumers, and commercial and government entities. Our products include KarmaCare and Karmaceutical brands as well as carefully selected and validated partner products.